MedPath

Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis

Not Applicable
Completed
Conditions
Hemorrhage
Pelvic Fracture
Interventions
Device: Pelvic Binder
Registration Number
NCT02855060
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The purpose of this study is to determine whether the use of pelvic binders in the ambulance setting improves outcomes including mortality in patients with pelvic fractures.

Detailed Description

The goal of this prospective, randomized clinical trial is to determine whether prehospital use of a commercial pelvic binder will improve morbidity and mortality in patients with pelvic fractures. We hypothesize that prehospital placement of pelvic binders will reduce hemorrhage and need for resuscitation and will improve overall mortality in patients with pelvic fractures. In addition, we hypothesize that pelvic splinting via external compression will improve patients' pain regardless of whether they have a pelvic, acetabular, or proximal femur fracture.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Traumatic injury other than ground-level fall, and
  • Complaint of pelvic groin or hip pain, or
  • Pelvic or hip deformity, ecchymosis, or crepitus in an obtunded patient, or
  • Hemodynamic instability
Read More
Exclusion Criteria
  • Ground level fall
  • Penetrating pelvis injury without frank evidence of fracture
  • Obviously pregnant patients
  • Patients who are too small or too big for the binder
  • Priority 2 or 3 Trauma
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pelvic BinderPelvic BinderCommercially available device used to stabilize the pelvis
Primary Outcome Measures
NameTimeMethod
Mortality Rate30 day

Percentage of patients that experience mortality within 30 days of presentation will be compared between the two study arms

Secondary Outcome Measures
NameTimeMethod
Pain Scores - Visual Analog ScaleAt time of arrival to Emergency Department

Pain scores at presentation to hospital will be compared between the two study arms. Range 0-10. Higher scores indicate a worse outcome.

Number of Participants With Skin Complications After Pelvic Binder ApplicationFrom date of randomization to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year

The rate of occurrence of skin complications after binder application will be documented.

Length of Stay in HospitalFrom date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year

The total number of days the patient spent in the hospital

Number of Patients With Blood Transfusions48 hours

Number of Blood Transfusions within the first 48 hours after hospital admission

Trial Locations

Locations (1)

Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath